1. Home
  2. ICCC vs ALOT Comparison

ICCC vs ALOT Comparison

Compare ICCC & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • ALOT
  • Stock Information
  • Founded
  • ICCC 1982
  • ALOT 1969
  • Country
  • ICCC United States
  • ALOT United States
  • Employees
  • ICCC N/A
  • ALOT N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • ALOT Computer peripheral equipment
  • Sector
  • ICCC Health Care
  • ALOT Technology
  • Exchange
  • ICCC Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • ICCC 60.1M
  • ALOT 69.2M
  • IPO Year
  • ICCC 1987
  • ALOT N/A
  • Fundamental
  • Price
  • ICCC $6.46
  • ALOT $11.35
  • Analyst Decision
  • ICCC
  • ALOT
  • Analyst Count
  • ICCC 0
  • ALOT 0
  • Target Price
  • ICCC N/A
  • ALOT N/A
  • AVG Volume (30 Days)
  • ICCC 16.1K
  • ALOT 9.4K
  • Earning Date
  • ICCC 08-14-2025
  • ALOT 09-15-2025
  • Dividend Yield
  • ICCC N/A
  • ALOT N/A
  • EPS Growth
  • ICCC N/A
  • ALOT N/A
  • EPS
  • ICCC N/A
  • ALOT N/A
  • Revenue
  • ICCC $27,302,766.00
  • ALOT $156,030,000.00
  • Revenue This Year
  • ICCC N/A
  • ALOT N/A
  • Revenue Next Year
  • ICCC N/A
  • ALOT N/A
  • P/E Ratio
  • ICCC N/A
  • ALOT N/A
  • Revenue Growth
  • ICCC 28.29
  • ALOT 7.14
  • 52 Week Low
  • ICCC $3.34
  • ALOT $7.53
  • 52 Week High
  • ICCC $7.60
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.42
  • ALOT 59.28
  • Support Level
  • ICCC $6.25
  • ALOT $10.91
  • Resistance Level
  • ICCC $7.30
  • ALOT $11.66
  • Average True Range (ATR)
  • ICCC 0.34
  • ALOT 0.38
  • MACD
  • ICCC -0.03
  • ALOT -0.08
  • Stochastic Oscillator
  • ICCC 20.00
  • ALOT 44.90

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: